Novavax

Novavax, Inc. is an American biotechnology company based in Gaithersburg, Maryland that develops vaccines to counter serious infectious diseases. Prior to 2020, company scientists developed experimental vaccines for Ebola,... Wikipedia

  • Type:  Public
  • Traded as:  NASDAQ: nvax NVAX, Russell 2000 component, FWB
  • ISIN:  [ US6700024010]
  • Industry:  Biotechnology
  • Founded:  1987
  • Area served:  Worldwide
  • Key people:  Stanley Erck (CEO), Gregory Glenn (R&D)
  • Products:  Vaccines
  • Revenue:  $475.2 million (2020)
  • Number of employees:  791(2021)
  • Data source:  DuckDuckGo